Cure My Disease

Don't miss your cure!

 Log in / Sign up

New combo therapy for jaw pain shows promise in small trial

NCT ID NCT07463404

Disease control Sponsor: Suez Canal University Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tested a treatment for a common jaw joint problem called TMJ anterior displacement, where the joint disc slips out of place. The treatment involved flushing the joint (arthrocentesis), then injecting platelet-rich plasma (a concentrate of the patient's own healing cells) and giving an anti-inflammatory drug. The goal was to improve jaw movement, reduce pain, and stop clicking. The study included 20 adults aged 18 to 40 with this condition, and all participants completed the treatment.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Phase 3

Large-scale testing in a bigger group. Usually the last step before a treatment can be approved.

Participants

20 people

The number who actually took part.

Started

Dec 2023

Finished

Nov 2025

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 40 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * patients aged from 18 to 40 years old. * patients diagnosed with ID of TMJ, suffering from limited mandibular movements, joint pain and clicking. * Patients who are free from any systemic disease and controlled systemic disease (ASA I) (ASA II). * Patients willing to comply with the follow-up schedule and treatment protocol. * both genders are included Exclusion Criteria: * Patients with systemic diseases (ASA III, IV, V). * Patients who have myofascial pain dysfunction syndrome only. * Patients who have previous surgery in TMJ. * Patients who have previous arthrocentesis within 1 year. * Patients who received previous trauma to the joint. * Use of anticoagulants or immunosuppressive medications.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Temporomandibular joint internal derangement are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

temporomandibular joint dysfunction syndrome

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Temporomandibular joint internal derangement

Contacts and locations

Locations

  • faculty of dentistry Suez Canal university

    Ismailia, Egypt

More trials for these conditions

Other studies related to the condition(s) this trial covers.